内毒素血症在年龄相关性黄斑变性、青光眼和糖尿病视网膜病变中的探索
本文综述脂多糖(LPS)通过慢性内毒素血症参与年龄相关性黄斑变性、原发性开角型青光眼和糖尿病视网膜病变的机制。LPS激活视网膜固有免疫和结构细胞,触发促炎因子、氧化应激、补体激活和炎症小体激活,损害血视网膜屏障并促进新生血管。尽管直接人体证据有限,实验数据支持LPS在三种眼病中的机制作用,提示其作为生物标志物和治疗靶点的潜力。
要点
- 慢性内毒素血症可能通过肠道菌群失调连接微生物失衡与眼病。
- LPS激活视网膜免疫和结构细胞,引发炎症、氧化应激和补体级联。
- LPS损害血视网膜屏障、增加血管渗漏并促进新生血管形成。
核心结论
- 慢性内毒素血症在年龄相关性黄斑变性、原发性开角型青光眼和糖尿病视网膜病变的发病机制中可能起重要作用。
- LPS通过激活先天免疫系统、诱导炎症和氧化应激等机制损害视网膜,但直接人体证据仍有限。
- 针对LPS的多重作用可能产生创新的生物标志物和治疗靶点,以减缓或预防这些眼病的神经退行性、血管和炎症过程。
研究设计与样本
- 本文为综述,未报告系统检索范围或纳入文献的样本量。
主要发现
- LPS是革兰阴性菌成分,可强效激活先天免疫系统,通过细菌裂解或主动分泌进入体循环导致急性或慢性内毒素血症。
- 慢性内毒素血症常源于肠道菌群失调,可能将微生物失衡与眼病联系起来。
- 在视网膜内,LPS激活固有免疫和结构细胞,触发促炎细胞因子产生、氧化应激、补体级联激活和炎症小体激活。
- 这些免疫级联反应破坏血视网膜屏障完整性、增加血管渗漏并损害神经元存活。
- LPS暴露可刺激促血管生成因子分泌,促进视网膜内新生血管形成。
临床怎么用
- 本综述提示临床可关注慢性内毒素血症作为AMD、青光眼和DR的潜在机制,但尚无直接人体证据支持具体临床干预。
- 未来研究可探索LPS相关生物标志物用于这些眼病的风险分层或治疗监测。
- 针对LPS通路的治疗策略可能有助于减缓或预防视网膜神经退行性、血管和炎症过程,但需进一步验证。
局限性
- 直接人体证据仍然有限,主要基于实验数据支持LPS的机制作用。
- 本文为综述,未提供系统检索策略或纳入研究的详细样本量等信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lipopolysaccharide (LPS), a component of Gram-negative bacteria, is a potent activator of the innate immune system and has been implicated in the pathogenesis of eye diseases, including age-related macular degeneration (AMD), primary open-angle glaucoma (POAG), and diabetic retinopathy (DR). LPS enters systemic circulation through bacterial lysis or active secretion, leading to endotoxemia-either acute or chronic. Chronic endotoxemia, often resulting from gut dysbiosis, may link microbial imbalances to eye diseases. Indeed, chronic LPS exposure may contribute to both systemic and local inflammation. Within the retina, it activates resident immune and structural cells triggering pro-inflammatory cytokine production, oxidative stress, complement cascade activation, and inflammasome activation. These immune cascades compromise blood-retinal barrier integrity, increase vascular leakage, and impair neuronal viability. LPS exposure can stimulate the secretion of pro-angiogenic factors, promoting the development of neovascularization within the retina. Furthermore, the aging retina may be particularly vulnerable to LPS-mediated damage due to an increased exposure to LPS (linked to microbial dysbiosis and alterations of both intestinal and blood-retinal barriers) as well as a reduced capacity for repair. Although direct human evidence remains limited, emerging experimental data support a mechanistic role for LPS in AMD, glaucoma, and DR. This review emphasizes that addressing the impact of chronic endotoxemia represents a promising avenue for both understanding and treating eye diseases. Continued investigation into the multifaceted roles of LPS may yield innovative biomarkers and therapeutic targets to slow or prevent neurodegenerative, vascular, and inflammatory processes underlying conditions such as AMD, glaucoma, and DR.
引用
- Larsen PP, Linard M, Schweitzer C, et al. Exploring Endotoxemia in Age-Related Macular Degeneration, Glaucoma, and Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2026. PMID: 42560008. doi:10.1167/iovs.67.10.14
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。